Reata Pharmaceuticals — a rare disease drugmaker recently acquired by Biogen — filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27.
Read the full post on Becker's Hospital Review - Healthcare News
